Henry Schein Inc (HSIC)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$64.00
Buy
$74.97
$1.46 (+2.08%)
Prices updated at 15 May 2025, 13:00 EDT
| Prices minimum 15 mins delay
Prices in USD
Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 12,339m | 12,673m | |
| 3,860m | 4,016m | |
| 695m | 731m | |
| 5.63 | 5.77 | |
| 416m | 390m | |
| 851m | 912m | |
| Sales, General and administrative | 2,956m | 3,034m |
| Interest expenses | 87m | 131m |
| Provision for income taxes | 120m | 128m |
| Operating expenses | 3,165m | 3,285m |
| Income before taxes | 542m | 513m |
| Net income available to common shareholders | 416m | 390m |
| 3.18 | 3.07 | |
| Net interest income | -70m | -107m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 3.16 | 3.05 |
| Free cash flow per share | 4.8796 | 3.2633 |
| Book value/share | 28.2481 | 28.2145 |
| Debt equity ratio | 0.614774 | 0.615679 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 4,488m | 3,983m |
| Current liabilities | 2,683m | 2,803m |
| Total capital | 5,592m | 5,223m |
| Total debt | 2,741m | 2,870m |
| Total equity | 3,655m | 3,393m |
| Total non current liabilities | - | - |
| Loans | 1,937m | 1,830m |
| Total assets | 10,573m | 10,218m |
| Total liabilities | - | - |
| Cash and cash equivalents | 171m | 122m |
| Common stock | 129m | 124m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 117m | 171m |
| Cash dividends paid | - | - |
| 313m | 661m | |
| Investments (gains) losses | -1,135m | -430m |
| 171m | 122m | |
| Net income | - | - |
| 500m | 848m | |
| -187m | -187m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
